Kazuharu Kai

2.8k citations
38 papers · 1.2k indexed · h-index 18
Topics
Cancer-related Molecular Pathways (10 papers)Cancer Cells and Metastasis (9 papers)Advanced Breast Cancer Therapies (5 papers)

In The Last Decade

Kazuharu Kai

38 papers receiving 1.1k citations

Peers

Kazuharu Kai
Comparison fields: 5 of 88
  • Oncology 577
  • Molecular Biology 487
  • Cancer Research 443
  • Biomedical Engineering 187
  • Cell Biology 178
Replace James E. Verdone with:
James E. Verdone United States
Vanesa L. Silvestri Italy
T.S. Karin Eisinger‐Mathason United States
Gary Box United Kingdom
André Filipe Vieira Portugal
Ina Kurth Germany
Zhaomei Mu United States
Brian R. Stoll United States
Marlous Hoogstraat Netherlands
Ernst J.A. Steller Netherlands
Kazuharu Kai relative to James E. Verdone United States James E. Verdone's profile →
Citations per field
00.5×1.5×2.1×
James E. Verdone · 1×
Citations per year

Countries citing papers authored by Kazuharu Kai

Since Specialization
Citations

This map shows the geographic impact of Kazuharu Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuharu Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuharu Kai more than expected).

Fields of papers citing papers by Kazuharu Kai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuharu Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuharu Kai. The network helps show where Kazuharu Kai may publish in the future.

Co-authorship network of co-authors of Kazuharu Kai

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuharu Kai. A scholar is included among the top collaborators of Kazuharu Kai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuharu Kai. Kazuharu Kai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 17
2 30
3 89
4 22
5 40
6 17
7 5
8 42
9 8
10 16
11 59
12 23
13 75
14 45
15 114
16 77
17 7
18 18
19 1
20 32

About Kazuharu Kai

Kazuharu Kai is a scholar working on Oncology, Cancer Research and Hepatology, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Cancer Cells and Metastasis (9 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Cancer Research (443 citations), Oncology (577 citations) and Cell Biology (178 citations). Kazuharu Kai has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hideyuki Saya, Subrata Sen, Naoto T. Ueno, Hirotaka Iwase, Yoshimi Arima, Rachel L. Dittmar, Takayuki Iwamoto, Yutaka Yamamoto, Weijia Zhang and Lidong Qin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026